They may lower the dose or adjust the treatment plan so weight loss slows to a safer pace
And The Lowdown on How to get What You Need
Diabetologia 65:19251966 Ahmann AJ, Capehorn M, Charpentier G, Dotta F, Henkel E, Lingvay I, Holst AG, Annett MP, Aroda VR (2018) Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): a 56-week, open-label
Redox Biol 2016;8:199-204
Food and Drug Administration (FDA) prescribing information, Centers for Disease Control and Prevention (CDC) data, and peer-reviewed research from the National Library of Medicine (PubMed), but individual responses may vary
The ruling prevents compounding pharmacies from continuing to make copies of the popular weight-loss medications, which they had been permitted to do under FDA rules during the declared shortage